TNFRSF17 and Miyoshi myopathy: The afucosylated Fc portion has the benefit of promoting the binding of effector cells to BCMA positive MM cells and augment effector-mediated cytotoxicity by ADCC and ADCP as well as MMAF-induced apoptosis against MM cells [52].